Dolby Labs Files 8-K on Financial Condition & Operations
Ticker: DLB · Form: 8-K · Filed: Feb 1, 2024 · CIK: 1308547
| Field | Detail |
|---|---|
| Company | Dolby Laboratories, INC. (DLB) |
| Form Type | 8-K |
| Filed Date | Feb 1, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $0.30 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: earnings, financial-results, corporate-update
TL;DR
**Dolby Labs just dropped an 8-K on financial results, get ready for potential stock movement.**
AI Summary
Dolby Laboratories, Inc. filed an 8-K on February 1, 2024, to report its financial condition and other events. This filing indicates that the company is providing an update on its operations, likely including earnings or other significant financial disclosures, which is crucial for investors to understand the company's current performance and future outlook. For shareholders, this means new information is available that could impact the stock's valuation, making it essential to review the full details for any changes in revenue, profit, or strategic direction.
Why It Matters
This filing signals that Dolby Laboratories is releasing important financial updates, which can directly influence investor sentiment and the company's stock price. Investors should analyze the full report for details on performance and any strategic shifts.
Risk Assessment
Risk Level: medium — The filing itself is routine, but the undisclosed 'Results of Operations and Financial Condition' could contain positive or negative news, creating market uncertainty.
Analyst Insight
A smart investor would immediately seek out the full text of the 8-K to review the detailed 'Results of Operations and Financial Condition' and 'Other Events' to understand the specific financial performance and any material changes that could affect Dolby Laboratories' future.
Key Numbers
- $0.001 — par value per share (par value of Dolby Laboratories' Class A common stock)
Key Players & Entities
- Dolby Laboratories, Inc. (company) — registrant filing the 8-K
- February 1, 2024 (date) — date of earliest event reported and filing date
- 001-32431 (other) — Commission File Number for Dolby Laboratories
- DLB (other) — trading symbol for Dolby Laboratories' Class A common stock
- The New York Stock Exchange (other) — exchange where Dolby Laboratories' Class A common stock is registered
FAQ
What specific items are being reported in this 8-K filing by Dolby Laboratories, Inc.?
This 8-K filing by Dolby Laboratories, Inc. includes 'Results of Operations and Financial Condition', 'Other Events', and 'Financial Statements and Exhibits' as per the 'ITEM INFORMATION' section.
What is the earliest event reported date for this 8-K filing?
The earliest event reported date for this 8-K filing is February 1, 2024, as stated in the 'Date of Report (Date of earliest event reported)' section.
Where is Dolby Laboratories, Inc. incorporated and what is its business address?
Dolby Laboratories, Inc. is incorporated in Delaware and its principal executive offices are located at 1275 Market Street, San Francisco, CA 94103-1410.
What is the trading symbol and the exchange where Dolby Laboratories, Inc.'s Class A common stock is registered?
Dolby Laboratories, Inc.'s Class A common stock trades under the symbol DLB and is registered on The New York Stock Exchange.
Is Dolby Laboratories, Inc. considered an emerging growth company according to this filing?
No, the filing indicates with a '☐' (unchecked box) that the registrant is NOT checking the box for being an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act.
Filing Stats: 661 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2024-02-01 16:15:31
Key Financial Figures
- $0.001 — which registered Class A common stock, $0.001 par value DLB The New York Stock Ex
- $0.30 — he Company announced a cash dividend of $0.30 per share of Class A and Class B Common
Filing Documents
- d765735d8k.htm (8-K) — 27KB
- d765735dex991.htm (EX-99.1) — 162KB
- 0001193125-24-021860.txt ( ) — 323KB
- dlb-20240201.xsd (EX-101.SCH) — 3KB
- dlb-20240201_lab.xml (EX-101.LAB) — 17KB
- dlb-20240201_pre.xml (EX-101.PRE) — 11KB
- d765735d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Dolby Laboratories, Inc. dated February 1, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DOLBY LABORATORIES, INC. By: /s/ Robert Park Robert Park Senior Vice President and Chief Financial Officer (Principal Financial Officer) Date: February 1, 2024